中煙香港(06055.HK):預計年度淨利減少65%至75%
格隆匯 12 月 18日丨中煙香港(06055.HK)發佈公告,公司截至2020年12月31日止年度的淨利潤預期將錄得較2019年同年度減少介乎65%至75%。
公告稱,預期淨利潤減少主要歸因於:(i)受新型冠狀病毒(COVID-19)疫情對全球供應鏈及集裝箱運輸能力的影響,巴西及其他地區的煙葉產品裝運延遲,導致公司於本年度煙葉類產品進口業務的利潤大幅減少;及(ii)受疫情影響,中國及相關地區出入境人數大幅減少,導致上述區域的免税捲煙銷量大幅下降,從而令公司於本年度捲煙出口業務的利潤大幅減少。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.